PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
09-Sep-2024 Abivax presents first-half 2024 financial results ABIVAX
09-Sep-2024 SMC accepts bispecific antibody TECVAYLI®▼ (teclistamab) for eligible patients with relapsed and refractory multiple myeloma Johnson & Johnson
09-Sep-2024 Secarna Pharmaceuticals will present data at 6th Inflammasome Therapeutics Summit demonstrating the potential of ASOs to target the expression of NLRP3 Secarna Pharmaceuticals GmbH & Co. KG
09-Sep-2024 CureVac to Present First CVGBM Glioblastoma Cancer Vaccine Clinical Data at ESMO 2024 Congress CureVac
06-Sep-2024 Industry calls on government to boost investment in commercial clinical trial capacity to drive £3 billion extra economic growth, 26,000 new jobs ABPI
06-Sep-2024 Original-Research: M1 Kliniken AG (von First Berlin Equity Research GmbH) M1 Kliniken AG
06-Sep-2024 Flex Databases - Top Clinical Trial Management Provider 2024 Flex Databases
05-Sep-2024 Respected pharma data science pioneer Dr Ben Sidders to spearhead Biorelate’s next growth phase as Chief Scientific Officer Biorelate
05-Sep-2024 Preliminary IFRS result for the first half of 2024 EBIT increases significantly to 75.7 mn euros. Equity increases by EUR 74.5 mn to EUR 325.5 mn, which corresponds to EUR 76.02 per share. MPH Health Care AG
05-Sep-2024 Original-Research: Cantourage Group SE (von NuWays AG) Cantourage Group SE
05-Sep-2024 Biotest AG opens 13th plasma collection center in Germany Biotest AG
05-Sep-2024 Promotion for SCHOTT Pharma: Listed on the MDAX for the first time SCHOTT Pharma AG & Co. KGaA
04-Sep-2024 MeVis Medical Solutions AG: Adjusting forecast for the current fiscal year MeVis Medical Solutions AG
04-Sep-2024 MHRA licenses first in new class of treatment for patients with endometriosis symptoms in the UK Gedeon Richter UK Ltd
04-Sep-2024 Envirotainer completes integration of va-Q-tec’s pharma business, advancing the future of pharma cold chain Envirotainer
04-Sep-2024 Actimed Therapeutics Announces US FDA Grant of Orphan Drug Designation to S-oxprenolol (ACM-002) for the Treatment of Amyotrophic Lateral Sclerosis (ALS) Actimed Therapeutics
04-Sep-2024 FDB Recognized as a Top Workplace in San Francisco Bay Area FDB
04-Sep-2024 Secarna establishes Scientific Advisory Board with leading oncology experts Prof. Dr. Eggermont and Prof. Dr. Zippelius Secarna Pharmaceuticals GmbH & Co. KG
04-Sep-2024 Immunic Announces First Patient Enrolled in Investigator-Sponsored Phase 2 Clinical Trial of Vidofludimus Calcium in Patients with Post COVID Syndrome Immunic AG
04-Sep-2024 Mainz Biomed Partners with Liquid Biosciences to Leverage the Power of Artificial Intelligence for the Expansion and Optimization of Biomarker Selection for PancAlert Mainz BioMed N.V.